BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15013715)

  • 1. Extended surgery for cancer of the esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    J Surg Res; 2004 Mar; 117(1):58-63. PubMed ID: 15013715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
    Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
    Lerut T; Nafteux P; Moons J; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Ectors N
    Ann Surg; 2004 Dec; 240(6):962-72; discussion 972-4. PubMed ID: 15570202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
    Cense HA; van Eijck CH; Tilanus HW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for radical esophagectomy.
    Lerut T; Coosemans W; De Leyn P; Decker G; Deneffe G; Van Raemdonck D
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S44-7. PubMed ID: 10536946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas.
    Vrouenraets BC; van Lanschot JJ
    Surg Oncol Clin N Am; 2006 Oct; 15(4):781-91. PubMed ID: 17030273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
    Peracchia A; Bonavina L; Via A; Incarbone R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP; Schröder W; Beckurts KT; Hölscher AH
    Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy.
    Dresner SM; Griffin SM
    Br J Surg; 2000 Oct; 87(10):1426-33. PubMed ID: 11044172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?
    D'Journo XB; Doddoli C; Michelet P; Loundou A; Trousse D; Giudicelli R; Fuentes PA; Thomas PA
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):697-704. PubMed ID: 15784377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
    Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
    Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
    Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
    Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.